FINETTI FEDERICA

Federica
Finetti
Ricercatore Legge 240/10 - tempo determinato

Teaching activities

Completion accademic year: 2024/2025

Completion accademic year: 2023/2024

Completion accademic year: 2022/2023

Completion accademic year: 2021/2022

Completion accademic year: 2020/2021

Course year: 3 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2018/2019
Course year: 3 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2018/2019
Course year: 2 First cycle degree (DM 270) CHEMICAL SCIENCES A.Y. 2019/2020

Completion accademic year: 2019/2020

Course year: 2 First cycle degree (DM 270) CHEMICAL SCIENCES A.Y. 2018/2019

Research

Ultime pubblicazioni:

  • Finetti, F., Paradisi, L., Bernardi, C., Pannini, M., Trabalzini, L. (2023). Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy. CANCERS, 15(8), 1-16 [10.3390/cancers15082374]. - view more
  • Bernardi, C., Macrì, G., Biagi, M., Miraldi, E., Finetti, F., Trabalzini, L. (2023). In vitro Digestion of Phaseolus vulgaris L. Cooked Beans Induces Autophagy in Colon Cancer Cells. FOODS, 12(4), 1-16 [10.3390/foods12040839]. - view more
  • Trabalzini, L., Tundis, R., Valacchi, G., Evelson, P.A., Finetti, F. (2022). Editorial: Angiogenesis and Nutraceuticals. FRONTIERS IN PHARMACOLOGY, 13 [10.3389/fphar.2022.943158]. - view more
  • Migliorini, F., Cini, E., Dreassi, E., Finetti, F., Ievoli, G., Macrì, G., et al. (2022). A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery. CHEMICAL COMMUNICATIONS, 58(75), 10532-10535 [10.1039/D2CC03052G]. - view more
  • Trabalzini, L., Ercoli, J., Trezza, A., Schiavo, I., Macrì, G., Moglia, A., et al. (2022). Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(15), 8534 [10.3390/ijms23158534]. - view more